Percutaneous coronary intervention increases leptin and decreases adiponectin levels

Area of Science:

• Cardiovascular medicine
• Metabolic research
• Inflammation and immunology

Background:

• Percutaneous coronary intervention (PCI) is known to induce a systemic inflammatory response.
• Adiponectin and leptin are key adipokines implicated in metabolic syndrome and diabetes pathogenesis.
• Understanding the impact of PCI on these adipokines is crucial for metabolic health assessment.

Purpose of the Study:

• To investigate the effect of PCI on circulating levels of adiponectin and leptin.
• To explore the relationship between PCI-induced inflammation and changes in adipokine levels.
• To test the hypothesis that inflammation modulates adiponectin and leptin in the context of PCI.

Main Methods:

• A prospective study design was employed, inducing inflammation via PCI.
• Forty-eight patients with stable coronary artery disease, without diabetes, were enrolled.
• Measurements included high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), leptin, and adiponectin at baseline and 48 hours post-PCI.

Main Results:

• PCI led to significant increases in hs-CRP (211%), IL-6 (87%), and leptin (19%).
• Adiponectin levels decreased by 14% following PCI (P < 0.001 for all changes).
• IL-6 changes correlated with hs-CRP and leptin, but adiponectin changes did not correlate with other markers.

Conclusions:

• PCI demonstrably alters adiponectin and leptin levels within 48 hours.
• These alterations in adipokine levels are likely secondary to the inflammatory response triggered by PCI.
• The findings suggest a potential link between PCI-induced inflammation and metabolic dysregulation via adipokine modulation.